Testing KarXT for schizophrenia
Explore this study →
Sites in Calgary, Edmonton and 3 more cities
Official title: A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively
Schizophrenia · Karuna Therapeutics, Inc., a Bristol Myers Squibb company